...
首页> 外文期刊>Journal of Cardiovascular Disease Research >Comparative Analysis of Clinical Profile of Patients Admitted with Idiopathic Dilated Cardiomyopathy in a Tertiary Care Hospital
【24h】

Comparative Analysis of Clinical Profile of Patients Admitted with Idiopathic Dilated Cardiomyopathy in a Tertiary Care Hospital

机译:三级医院特发性扩张型心肌病患者的临床资料比较分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The etiology of the ventricular dilation and dysfunction that occurs in idiopathic dilated cardiomyopathy (DCM) is unknown. Aim: The present study was aimed to study clinical characteristics of the patients admitted with idiopathic DCM and compare them with healthy controls. Methods: Thirty newly diagnosed patients with DCM and 30 healthy control were enrolled from Cardiology OPD, PGIMER, Chandigarh from Jan 2011 to Jun 2012. Patients with heart failure secondary to idiopathic DCM of age >18 years were included if they were willing, provide written informed consent and does not meet any of the exclusion criteria. Idiopathic DCM was diagnosed by the presence of left ventricular dilatation and systolic dysfunction (LVEF<40%) on echocardiography in the absence of coronary artery disease, hypertension or valvular disease. Results: Mean age of idiopathic DCM patients and control was 48.37±10.82 years and 49.2±9.27 (P=0.75) respectively. There were more males (66.7%) than females (33.3%) in the patient group. It was observed that the treatment with beta blockers, furosemide, spironolactone, ACE inhibitors, and ARBs significantly improved ejection fraction (EF) (P=0.000), and LVES (P=0.000). Conclusion: In our study, treatment with the medications significantly improved EF and LVES. However, there was no treatment-based difference in the patients on ACE inhibitors or ARBs in the improvement in EF. Our study also observed significance difference in platelets count, SGOT, SGPT, and LDL levels in idiopathic DCM patients when compared with healthy controls.
机译:背景:特发性扩张型心肌病(DCM)中发生的心室扩张和功能障碍的病因尚不清楚。目的:本研究旨在研究特发性DCM入院患者的临床特征,并将其与健康对照进行比较。方法:2011年1月至2012年6月,从Cardiology OPD,PGIMER,Chandigarh招募了30例新诊断的DCM患者和30名健康对照者。如果愿意,则包括因年龄大于18岁的特发性DCM继发的心力衰竭患者,并提供书面报告。知情同意书,不符合任何排除标准。在没有冠心病,高血压或瓣膜疾病的情况下,通过超声心动图检查发现左心室扩张和收缩功能障碍(LVEF <40%)可诊断为特发性DCM。结果:特发性DCM患者和对照组的平均年龄分别为48.37±10.82岁和49.2±9.27(P = 0.75)。患者组中男性(66.7%)多于女性(33.3%)。观察到,用β受体阻滞剂,速尿,螺内酯,ACEI抑制剂和ARB进行治疗可显着改善射血分数(EF)(P = 0.000)和LVES(P = 0.000)。结论:在我们的研究中,用药物治疗可显着改善EF和LVES。然而,ACE抑制剂或ARBs患者在EF改善方面无基于治疗的差异。我们的研究还观察到与健康对照组相比,特发性DCM患者的血小板计数,SGOT,SGPT和LDL水平存在显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号